Logo

Biodesix

In Brief This Week: Yourgene, Centogene, Epigenomics, AnPac Bio-Medical, Biodesix, SomaLogic

News items for the week of Dec. 19, 2022.

In Brief This Week: Biocept, Thermo Fisher, Biodesix, More

News items for the week of Nov. 21, 2022.

Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement

Earlier this month, the Boulder, Colorado-based diagnostics firm reported ending the third quarter with $15.2 million in cash and cash equivalents.

In Brief This Week: Sophia Genetics, Sense Biodetection, Yourgene, Biodesix, DermTech, Chembio, More

News items for the week of Oct. 31, 2022.

Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests

The company's full lung cancer diagnostic menu will be covered for eligible veterans, active-duty military, and their families.

Oct 14, 2022

In Brief This Week: Thermo Fisher Scientific, Enzo Biochem, Codex DNA, More

Aug 5, 2022

Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen

Jun 3, 2022

Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test

May 11, 2022

Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results

Apr 11, 2022

Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement

Mar 14, 2022

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Mar 8, 2022

Biodesix Inks $50M Stock Sale Agreement

Jan 21, 2022

New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More

Jan 5, 2022

Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan

Dec 1, 2021

Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests

Nov 15, 2021

Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates

Oct 27, 2021

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians
Premium

Aug 10, 2021

Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations

Jun 4, 2021

Biodesix, Datavant Join in Lung Cancer Data Partnership

May 11, 2021

Biodesix Q1 Revenues Soar on COVID-19 Testing

Apr 19, 2021

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

Mar 24, 2021

Biodesix Secures $30M Term Loan

Mar 16, 2021

Biodesix Q4 Revenues More Than Triple on COVID-19 Testing

Jan 8, 2021

Biodesix Preliminary Q4 Revenues Up Over 200 Percent

Dec 11, 2020

Biodesix Q3 Revenues Rise Sharply

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.